NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 11 04:00PM ET
1.72
Dollar change
+0.03
Percentage change
1.78
%
Index- P/E- EPS (ttm)-0.06 Insider Own- Shs Outstand239.91M Perf Week39.84%
Market Cap412.65M Forward P/E- EPS next Y- Insider Trans- Shs Float22.85M Perf Month26.47%
Enterprise Value326.12M PEG- EPS next Q- Inst Own0.09% Short Float0.14% Perf Quarter86.94%
Income-6.61M P/S48.78 EPS this Y- Inst Trans-8.24% Short Ratio0.94 Perf Half Y21.13%
Sales8.46M P/B2.06 EPS next Y- ROA-5.75% Short Interest0.03M Perf YTD26.47%
Book/sh0.84 P/C4.52 EPS next 5Y- ROE-6.43% 52W High2.35 -26.90% Perf Year68.63%
Cash/sh0.38 P/FCF- EPS past 3/5Y56.50% - ROIC-3.30% 52W Low0.74 132.34% Perf 3Y57.80%
Dividend Est.- EV/EBITDA- Sales past 3/5Y11.22% -47.64% Gross Margin3.27% Volatility25.99% 10.33% Perf 5Y-28.44%
Dividend TTM- EV/Sales38.55 EPS Y/Y TTM73.66% Oper. Margin-81.48% ATR (14)0.18 Perf 10Y-
Dividend Ex-DateAug 01, 2018 Quick Ratio8.18 Sales Y/Y TTM280.14% Profit Margin-78.14% RSI (14)65.92 Recom-
Dividend Gr. 3/5Y- - Current Ratio8.19 EPS Q/Q40.33% SMA2027.14% Beta-0.68 Target Price4.00
Payout- Debt/Eq0.02 Sales Q/Q25.47% SMA5019.04% Rel Volume1.08 Prev Close1.69
Employees- LT Debt/Eq0.00 EarningsMar 28 BMO SMA20041.00% Avg Volume34.94K Price1.72
IPONov 03, 2017 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume37,766 Change1.78%
Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Qingdao, China.